This content is viewable by members only. Visit MY ACCOUNT on the top menu to log in or to register for a 30 day free trial or purchase a subscription for UV Reporter 1 Year Single Membership or UV Reporter 1 Year Group Membership - $189 for first member and $25 for each additional member.
Glaukos Corp. with UV Corneal Drug Activation Delivers 10-K Annual Report to the SEC
Glaukos Corp. 10-K Annual Report covering 2022 ending 12/31/22 delivered to the SEC on February 24, 2023. See filing at: https://tinyurl.com/2ozzx2r9 Critical Accounting Policies and…
Published in Informational
More from InformationalMore posts in Informational »
- UV Business News – Veralto Corp. File Form 10-Q With SEC
- Bengaluru, India Wastewater Treatment System Uses UV Disinfection
- Do GUV222 Systems Pose a Pollution Problem?
- Portland, OR City Council Chooses Filtration Over UV Disinfection To Meet Water Quality Requirements
- UV Emitting Glass Stops Bacterial Growth on Imaging Devices And Underwater Glass Ports